Resultados de búsqueda - Hege Frøen
- Mostrando 1 - 2 Resultados de 2
-
1
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up por Trine‐Lise Larsen, Herish Garresori, Jorunn Brekke, Tone Enden, Hege Frøen, E. Jacobsen, Petter Quist‐Paulsen, Alina Carmen Porojnicu, Anne Hansen Ree, Dag Torfoss, Elin Osvik Velle, Hilde Skuterud Wik, Waleed Ghanima, Per Morten Sandset, Anders Erik Astrup Dahm
Publicado 2022Artigo -
2
Cold agglutinin disease revisited: a multinational, observational study of 232 patients por Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, Ulla Randen, Tor Henrik Anderson Tvedt, Bruno Fattizzo, Einar Haukås, Megan Kell, Robert Brudevold, Anders Erik Astrup Dahm, Jakob Dalgaard, Hege Frøen, Randi Fykse Hallstensen, Pernille H. Jæger, Henrik Hjorth‐Hansen, Agnieszka Małecka, Markku Oksman, Jürgen Rolke, Mallika Sekhar, Jon Hjalmar Sørbø, Eirik Tjønnfjord, Galina Tsykunova, Geir E. Tjønnfjord
Publicado 2020Artigo
Herramientas de búsqueda:
Materias Relacionadas
Internal medicine
Medicine
Surgery
Anemia
Apixaban
Atrial fibrillation
Autoimmune hemolytic anemia
Bendamustine
Cancer
Chemotherapy
Cold agglutinin disease
Cyclophosphamide
Environmental health
Fludarabine
Gastroenterology
Lymphoma
Population
Regimen
Rituximab
Rivaroxaban
Secondary prevention
Secondary prophylaxis
Thrombosis
Venous thromboembolism
Warfarin